Using cyclosporine in the COVID era: An emergent need for caution

J Am Acad Dermatol. 2020 Oct;83(4):e315-e316. doi: 10.1016/j.jaad.2020.06.990. Epub 2020 Jun 27.

Authors

Ananta Khurana¹, Khushboo Sethia²

Affiliations

¹ Department of Dermatology, Dr. Ram Manohar Lohia Hospital & Atal Bihari Vajpayee Institute of Medical Sciences, New Delhi, India. Electronic address: drananta2014@gmail.com.
² Department of Dermatology, Dr. Ram Manohar Lohia Hospital & Atal Bihari Vajpayee Institute of Medical Sciences, New Delhi, India.

No abstract available

Publication types

Letter
Comment

MeSH terms

COVID-19*
Cyclosporine / adverse effects
Humans
Immunosuppressive Agents / adverse effects
Pandemics*
SARS-CoV-2

Substances

Immunosuppressive Agents
Cyclosporine